| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target. | Surgery | 2013 | 0.95 |
| 2 | Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer. | Ann Surg | 2012 | 0.78 |